Reproductive Hormones and Proteins Tests – Medical Devices Pipeline Assessment, 2019

Reproductive Hormones and Proteins Tests assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine function (such as the pancreas, liver, kidneys, and gonads) and affect the health and behavior of both males and females. GlobalData's Medical Devices sector report, “Reproductive Hormones and Proteins Tests – Medical Devices Pipeline Assessment, 2019" provides comprehensive information about the Reproductive Hormones and Proteins Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Reproductive Hormones and Proteins Tests Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Reproductive Hormones and Proteins Tests under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Reproductive Hormones and Proteins Tests pipeline products.

Review of Recent Developments in the segment / industry

The Reproductive Hormones and Proteins Tests Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Reproductive Hormones and Proteins Tests under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2009 and forecast to 2023

• 4,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape

• 56,000+ medical equipment company profiles

• 4,300+ company profiles of medical equipment manufacturers in China and India

• 2,000+ company profiles of medical equipment manufacturers in Japan

• 825+ companies’ revenue splits and market shares

• 1,900+ quarterly and annual medical equipment company financials

• 940+ medical equipment company SWOTs

• 21,500+ pipeline product profiles

• 34,500+ marketed product profiles

• 36,000+ clinical trials

• 36,500+ trial investigators

• 5,400+ reports on companies with products in development

• 33,000+ deals in the medical equipment industry

• 1,300+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Reproductive Hormones and Proteins Tests under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Reproductive Hormones and Proteins Tests and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Reproductive Hormones and Proteins Tests under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

AgPlus Diagnostics LTD

Albert Einstein College of Medicine

Aura Biotechnologies Pvt Ltd

Beckman Coulter Inc

Boditech Med Inc

Bruyere Research Institute

China Medical Technologies Inc (Inactive)

DiaSorin SpA

Ellume Ltd

Fujirebio Diagnostics Inc

Genovum Sp. z o.o.

Hebrew University of Jerusalem

Immunodiagnostic Systems Holdings plc

King's College London

Labsystems Diagnostics Oy

Lucine Biotechnology, Inc.

Northwestern University

Paramedical Srl

PerkinElmer Inc

Proteomika (Inactive)

QuickCheck Health Inc

redhot diagnostics AB

Roche Diagnostics International Ltd

Shahid Beheshti University

Shenzhen Mindray Bio-Medical Electronics Co Ltd

Siemens Healthcare Diagnostics Inc

Siemens Healthineers AG

SomaLogic Inc

Swan Diagnostics Ltd

Sysmex Corp

Thermo Fisher Scientific Inc

University of Edinburgh

University of Otago

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Reproductive Hormones and Proteins Tests Overview 8

3 Products under Development 9

3.1 Reproductive Hormones and Proteins Tests – Pipeline Products by Stage of Development 9

3.2 Reproductive Hormones and Proteins Tests – Pipeline Products by Segment 10

3.3 Reproductive Hormones and Proteins Tests – Pipeline Products by Territory 11

3.4 Reproductive Hormones and Proteins Tests – Pipeline Products by Regulatory Path 12

3.5 Reproductive Hormones and Proteins Tests – Pipeline Products by Estimated Approval Date 13

4 Reproductive Hormones and Proteins Tests – Pipeline Products under Development by Companies 14

4.1 Reproductive Hormones and Proteins Tests Companies – Pipeline Products by Stage of Development 14

4.2 Reproductive Hormones and Proteins Tests – Pipeline Products by Stage of Development 16

5 Reproductive Hormones and Proteins Tests Companies and Product Overview 18

5.1 AgPlus Diagnostics LTD Company Overview 18

5.1.1 AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 Albert Einstein College of Medicine Company Overview 19

5.2.1 Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Aura Biotechnologies Pvt Ltd Company Overview 20

5.3.1 Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 Beckman Coulter Inc Company Overview 21

5.4.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Boditech Med Inc Company Overview 22

5.5.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Bruyere Research Institute Company Overview 23

5.6.1 Bruyere Research Institute Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 China Medical Technologies Inc (Inactive) Company Overview 24

5.7.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 DiaSorin SpA Company Overview 25

5.8.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 25

5.9 Ellume Ltd Company Overview 27

5.9.1 Ellume Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 Fujirebio Diagnostics Inc Company Overview 28

5.10.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 Genovum Sp. z o.o. Company Overview 31

5.11.1 Genovum Sp. z o.o. Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 Hebrew University of Jerusalem Company Overview 32

5.12.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 Immunodiagnostic Systems Holdings plc Company Overview 34

5.13.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 34

5.14 King's College London Company Overview 36

5.14.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 36

5.15 Labsystems Diagnostics Oy Company Overview 37

5.15.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 37

5.16 Lucine Biotechnology, Inc. Company Overview 38

5.16.1 Lucine Biotechnology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

5.17 Northwestern University Company Overview 39

5.17.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 39

5.18 Paramedical Srl Company Overview 41

5.18.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 41

5.19 PerkinElmer Inc Company Overview 42

5.19.1 PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.20 Proteomika (Inactive) Company Overview 43

5.20.1 Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 43

5.21 QuickCheck Health Inc Company Overview 44

5.21.1 QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.22 redhot diagnostics AB Company Overview 45

5.22.1 redhot diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 45

5.23 Roche Diagnostics International Ltd Company Overview 46

5.23.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.24 Shahid Beheshti University Company Overview 48

5.24.1 Shahid Beheshti University Pipeline Products & Ongoing Clinical Trials Overview 48

5.25 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 49

5.25.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.26 Siemens Healthcare Diagnostics Inc Company Overview 53

5.26.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53

5.27 Siemens Healthineers AG Company Overview 58

5.27.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 58

5.28 SomaLogic Inc Company Overview 61

5.28.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.29 Swan Diagnostics Ltd Company Overview 62

5.29.1 Swan Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

5.30 Sysmex Corp Company Overview 63

5.30.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 63

5.31 Thermo Fisher Scientific Inc Company Overview 65

5.31.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.32 University of Edinburgh Company Overview 66

5.32.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 66

5.33 University of Otago Company Overview 67

5.33.1 University of Otago Pipeline Products & Ongoing Clinical Trials Overview 67

6 Reproductive Hormones and Proteins Tests- Recent Developments 68

6.1 Oct 30, 2019: Quidel reports third quarter 2019 financial results 68

6.2 Oct 30, 2019: PerkinElmer announces financial results for the third quarter of 2019 69

6.3 Oct 23, 2019: bioMerieux – Third-Quarter 2019 Business Review 70

6.4 Oct 22, 2019: bioMerieux – Third quarter 2019 business review 72

6.5 Oct 16, 2019: Abbott reports third-quarter 2019 results 73

6.6 Oct 16, 2019: Biomerica reports 1st quarter fiscal 2020 financials 76

6.7 Oct 10, 2019: Clearblue partners with Be My Eyes to provide accessible service vision-impaired women across the globe deserve 76

6.8 Oct 01, 2019: Fortress Diagnostics announces £8m investment in new headquarters 77

6.9 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report 78

6.10 Sep 04, 2019: bioMerieux announces First-Half 2019 Results 79

6.11 Aug 30, 2019: Biomerica announces fiscal year end 2019 financial results 82

6.12 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 83

6.13 Aug 21, 2019: PerkinElmer announces leadership succession plan 84

6.14 Aug 08, 2019: Quidel reports second quarter 2019 Financial Results 84

6.15 Jul 29, 2019: PerkinElmer announces financial results for the second quarter of 2019 86

6.16 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 87

6.17 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 88

6.18 Jul 17, 2019: Abbott reports second-quarter 2019 results 89

6.19 Jul 15, 2019: EKF Diagnostics Holdings: Trading update 92

6.20 Jun 19, 2019: Immunodiagnostic Systems Holdings: Final results for year ended 31 March 2019 92

6.21 Jun 01, 2019: Greg Milosevich appointed President of Beckman Coulter Life Sciences 93

6.22 May 27, 2019: Sysmex and Osaka University sign comprehensive collaboration agreement to foster innovation in the healthcare field 93

6.23 May 22, 2019: Serving the needs of the medical front and creating new value the start of a New Medical Device and Reagent Brand: "The Lab" 94

6.24 May 08, 2019: Quidel reports first quarter 2019 financial results 95

6.25 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 96

6.26 Apr 26, 2019: Fujirebio launches the automated Lumipulse G AMH assay for accurate assessment of ovarian reserve 97

6.27 Apr 25, 2019: PerkinElmer Announces Financial Results for the First Quarter of 2019 98

6.28 Apr 24, 2019: bioMerieux: First-quarter 2019 business review 99

6.29 Apr 18, 2019: Sekisui Diagnostics announces the launch of the FastPack IP SHBG Test 100

6.30 Apr 18, 2019: Immunodiagnostic Systems Holdings: FY2019 trading update 101

6.31 Apr 17, 2019: Abbott reports first-quarter 2019 results 103

6.32 Apr 16, 2019: Biomerica announces third quarter financial results 105

6.33 Mar 19, 2019: Abbott introduces new digital service in India as part of its global a:care program 106

6.34 Mar 13, 2019: EKF Diagnostics Holdings: Final results 108

6.35 Mar 07, 2019: Mindray signs patient safety movement’s open data pledge & becomes 90th company to join to improve patient safety 113

6.36 Feb 27, 2019: bioMerieux – 2018 Financial Results 114

6.37 Feb 22, 2019: Abbott planning $62M expansion in Columbus, adding 38 jobs 117

6.38 Feb 16, 2019: New chair of Irish Studies appointed 117

6.39 Feb 13, 2019: Quidel Reports Fourth Quarter and Full Year 2018 Financial Results 117

6.40 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim 119

6.41 Jan 31, 2019: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2018 120

6.42 Jan 29, 2019: Qualigen receives FDA clearance for its FastPack IP SHBG Assay 121

6.43 Jan 23, 2019: Abbott reports 2018 results and issues strong forecast for 2019 122

6.44 Jan 15, 2019: Biomerica announces second quarter financial results 124

6.45 Jan 10, 2019: ARKRAY Commences Overseas Remote Maintenance Services for Medical Devices 124

6.46 Jan 07, 2019: Quidel Announces Preliminary Revenue for Fourth Quarter 2018 126

6.47 Dec 20, 2018: Strengthening Global Research and Development Networks AI Software Development facility established in India 126

6.48 Dec 12, 2018: Sera Prognostics receives New York State approval for PreTRM testing 126

6.49 Dec 10, 2018: PerkinElmer names Prahlad Singh as president & chief operating officer 127

6.50 Dec 04, 2018: ARKRAY expands to its 13th Country with a new branch in Dubai 128

6.51 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed 128

6.52 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed 129

6.53 Nov 30, 2018: Eveline Smart Ovulation Test is awarded 15th National Innovation Award! 130

6.54 Nov 27, 2018: Sera Prognostics completes enrollment of large, multicenter, prospective clinical study of PreTRM test 130

7 Appendix 132

7.1 Methodology 132

7.2 About GlobalData 135

7.3 Contact Us 135

7.4 Disclaimer 135

List of Tables

Table 1: Reproductive Hormones and Proteins Tests – Pipeline Products by Stage of Development 9

Table 2: Reproductive Hormones and Proteins Tests – Pipeline Products by Segment 10

Table 3: Reproductive Hormones and Proteins Tests – Pipeline Products by Territory 11

Table 4: Reproductive Hormones and Proteins Tests – Pipeline Products by Regulatory Path 12

Table 5: Reproductive Hormones and Proteins Tests – Pipeline Products by Estimated Approval Date 13

Table 6: Reproductive Hormones and Proteins Tests Companies – Pipeline Products by Stage of Development 14

Table 7: Reproductive Hormones and Proteins Tests – Pipeline Products by Stage of Development 16

Table 8: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 18

Table 11: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 19

Table 14: Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

Table 17: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Table 20: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Table 23: Bruyere Research Institute Pipeline Products & Ongoing Clinical Trials Overview 23

Table 26: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24

Table 29: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 25

Table 34: Ellume Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Table 37: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Table 44: Genovum Sp. z o.o. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 47: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 32

Table 52: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 34

Table 59: King's College London Pipeline Products & Ongoing Clinical Trials Overview 36

Table 62: Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 37

Table 65: Lucine Biotechnology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 68: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 39

Table 73: Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 41

Table 76: PerkinElmer Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Table 79: Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 43

Table 82: QuickCheck Health Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 85: redhot diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 45

Table 88: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Table 95: Shahid Beheshti University Pipeline Products & Ongoing Clinical Trials Overview 48

Table 98: Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Table 109: Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53

Table 124: Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 58

Table 131: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Table 134: Swan Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

Table 137: Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 63

Table 142: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Table 145: University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 66

Table 148: University of Otago Pipeline Products & Ongoing Clinical Trials Overview 67

Table 151: Glossary 134

List of Figures

Figure 1: Reproductive Hormones and Proteins Tests – Pipeline Products by Stage of Development 9

Figure 2: Reproductive Hormones and Proteins Tests – Pipeline Products by Segment 10

Figure 3: Reproductive Hormones and Proteins Tests – Pipeline Products by Territory 11

Figure 4: Reproductive Hormones and Proteins Tests – Pipeline Products by Regulatory Path 12

Figure 5: Reproductive Hormones and Proteins Tests – Pipeline Products by Estimated Approval Date 13

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports